Dishman Carbogen Amcis Stock Screener | Share Price & Fundamental Analysis
DCAL
Pharmaceuticals
Screen Dishman Carbogen Amcis share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price NSE
₹254.87
▲
0.09 (0.04%)
Share Price BSE
₹255.15
▲
0.50 (0.20%)
Market Cap
₹3,882.58 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
0.60
EPS (TTM)
₹0.21
Dividend Yield
-
Debt to Equity
0.41
52W High
₹314.00
52W Low
₹219.68
Operating Margin
20.00%
Profit Margin
5.94%
Revenue (TTM)
₹724.00
EBITDA
₹149.00
Net Income
₹43.00
Total Assets
₹9,999.00
Total Equity
₹5,832.00
Dishman Carbogen Amcis Share Price History - Stock Screener Chart
Screen DCAL historical share price movements with interactive charts. Analyze price trends and patterns.
Dishman Carbogen Amcis Company Profile - Fundamental Screener
Screen Dishman Carbogen Amcis company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for DCAL shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE385W01011
Dishman Carbogen Amcis Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen DCAL balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Total Assets | 9,999 | 9,581 | 9,454 | 8,638 | 8,366 | 8,200 | 7,329 | 7,177 | 6,593 |
| Current Assets | 2,200 | 1,928 | 1,918 | 1,839 | 1,704 | 1,779 | 1,554 | 1,546 | 1,245 |
| Fixed Assets | 7,055 | 6,724 | 6,188 | 5,773 | 5,698 | 5,678 | 5,098 | 5,066 | 4,852 |
| Liabilities | |||||||||
| Total Liabilities | 9,999 | 9,581 | 9,454 | 8,638 | 8,366 | 8,200 | 7,329 | 7,177 | 6,593 |
| Current Liabilities | 2,243 | 1,399 | 1,845 | 1,669 | 1,377 | 916 | 751 | 891 | 786 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | |||||||||
| Total Equity | 5,832 | 5,628 | 5,810 | 5,549 | 5,699 | 5,715 | 5,379 | 5,107 | 4,814 |
| Share Capital | 31 | 31 | 31 | 31 | 31 | 31 | 32 | 32 | 0 |
| Reserves & Surplus | 5,800 | 5,596 | 5,778 | 5,518 | 5,668 | 5,684 | 5,347 | 5,075 | 4,814 |
Screen DCAL income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept | 2022-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 724 | 733 | 661 | 662 | 525 | 796 | 690 | 625 | 730 | 595 | 657 | 573 | 546 | 623 | 646 |
| Expenses | 575 | 570 | 504 | 595 | 500 | 645 | 542 | 613 | 602 | 529 | 610 | 559 | 452 | 535 | 529 |
| EBITDA | 149 | 163 | 157 | 67 | 25 | 151 | 148 | 13 | 128 | 66 | 47 | 14 | 94 | 88 | 118 |
| Operating Profit % | 20.00% | 19.00% | 23.00% | 9.00% | 4.00% | 18.00% | 21.00% | 1.00% | 17.00% | 10.00% | 6.00% | 2.00% | 16.00% | 13.00% | 17.00% |
| Depreciation | 79 | 81 | 84 | 85 | 71 | 72 | 72 | 76 | 70 | 75 | 80 | 84 | 75 | 80 | 50 |
| Interest | 42 | 43 | 42 | 31 | 32 | 37 | 49 | 24 | 29 | 28 | 33 | 16 | 19 | 20 | 22 |
| Profit Before Tax | 28 | 39 | 31 | -49 | -78 | 42 | 27 | -88 | 30 | -36 | -66 | -85 | 0 | -12 | 46 |
| Tax | -15 | 15 | -35 | 21 | 0 | 9 | 22 | -17 | 13 | 5 | -7 | -41 | -4 | -2 | -1 |
| Net Profit | 43 | 23 | 65 | -70 | -78 | 33 | 5 | -71 | 17 | -41 | -60 | -45 | 4 | -10 | 47 |
| EPS | 2.75 | 1.49 | 4.16 | -4.46 | -4.95 | 2.11 | 0.30 | -4.51 | 1.08 | -2.61 | -3.80 | -2.85 | 0.26 | -0.64 | 3.00 |
Dishman Carbogen Amcis Cash Flow Screener - Liquidity Fundamentals
Screen DCAL cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2012-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 375 | 379 | 266 | 355 | 513 | 585 | 282 | 226 | 303 | 154 |
| Investing Activities | -196 | -225 | -494 | -619 | -380 | -442 | -169 | -297 | -107 | -104 |
| Financing Activities | -102 | -22 | 250 | 130 | -11 | -98 | -102 | 78 | -137 | -68 |
| Net Cash Flow | 77 | 132 | 22 | -133 | 122 | 46 | 11 | 7 | 59 | -19 |
Screen DCAL shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 59.32% | 59.32% | 59.32% | 59.32% | 59.32% | 59.32% | 59.32% | 59.32% |
| FII Holding | 9.49% | 9.93% | 8.07% | 8.70% | 8.04% | 8.17% | 8.74% | 0.00% |
| DII Holding | 1.26% | 1.27% | 1.37% | 2.37% | 1.48% | 1.23% | 1.42% | 2.56% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 25.31% | 25.36% | 26.84% | 25.17% | 27.10% | 27.43% | 26.22% | 24.61% |
| Other Holding | 4.62% | 4.11% | 4.39% | 4.45% | 4.06% | 3.85% | 4.29% | 13.50% |
| Shareholder Count | 50,757 | 49,744 | 49,455 | 50,656 | 53,683 | 55,280 | 52,822 | 56,583 |
Dishman Carbogen Amcis Dividend Screener - Share Yield Analysis
Screen DCAL dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2025-March | ₹0.00 | 0.00% |
| 2024-March | ₹0.00 | 0.00% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.20 | 0.37% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹1.20 | 0.37% |
| 2016-March | ₹0.00 | 0.00% |
Dishman Carbogen Amcis Index Membership - Market Screener Classification
Screen DCAL by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Dishman Carbogen Amcis Market Events Screener - Corporate Actions
Screen DCAL market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -4.79% | ||
| Annual General Meeting | NA | 3.83% | ||
| 2025-11-04 | 2025-11-04 | Quarterly Result Announcement | NA | -0.44% |
| 2025-08-12 | 2025-08-12 | Quarterly Result Announcement | NA | -0.81% |
| 2025-05-21 | 2025-05-21 | Quarterly Result Announcement | NA | 1.32% |
| 2025-02-12 | 2025-02-12 | Quarterly Result Announcement | NA | -5.97% |
| 2024-11-13 | 2024-11-13 | Quarterly Result Announcement | NA | -2.31% |
| 2017-03-27 | 2017-03-27 | Change Of Name | NA | - |
Dishman Carbogen Amcis Competitors Screener - Peer Comparison
Screen DCAL competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 412,470 | 39.35 | 54,729 | 9.71% | 10,980 | 39.06 |
| Divis Laboratories | 169,727 | 68.64 | 9,712 | 18.67% | 2,191 | 44.96 |
| Torrent Pharmaceuticals | 129,188 | 60.42 | 11,539 | 6.99% | 1,911 | 59.35 |
| Cipla | 121,028 | 22.17 | 28,410 | 7.12% | 5,291 | 42.76 |
| Dr Reddys Laboratories | 105,706 | 18.42 | 33,741 | 16.73% | 5,725 | 49.97 |
| Lupin | 95,718 | 21.87 | 22,910 | 13.74% | 3,306 | 50.10 |
| Zydus Life Science | 91,547 | 18.03 | 23,511 | 18.55% | 4,615 | 34.06 |
| Mankind Pharma | 89,868 | 50.11 | 12,744 | 20.90% | 2,007 | 40.67 |
| Aurobindo Pharma | 68,866 | 20.16 | 32,346 | 9.43% | 3,484 | 46.33 |
| Alkem Laboratories | 65,605 | 26.89 | 13,458 | 3.70% | 2,216 | 37.45 |
Dishman Carbogen Amcis Company Announcements - News Screener
Screen DCAL latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-01-02 | Board Meeting Outcome for BOARD MEETING OUTCOME FOR BOARD APPROVES ISSUE OF SENIOR SECURED RATED LISTED TRANSFERABLE TAXABLE REDEEMABLE NON-CONVERTIBLE DEBENTURES AGGREGATING UP TO RS. 50 CRORES | View |
| 2025-12-29 | Closure of Trading Window | View |
| 2025-12-29 | Board Meeting Intimation for Considering And Approving The Proposal Of Fund Raising By Way Of Issuance Of Non-Convertible Debentures By Way Of Private Placement Subject To Such Regulatory Or Statutory Approvals As May Be Required | View |
| 2025-12-26 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-11-12 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2025-11-11 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | View |
| 2025-11-05 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | View |
| 2025-11-05 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2025-11-05 | Announcement under Regulation 30 (LODR)-Investor Presentation | View |
| 2025-11-04 | Board Meeting Outcome for Unaudited Financial Results For The Quarter And Half Year Ended 30Th September 2025. | View |
| 2025-11-04 | Unaudited Financial Results For The Quarter And Half Year Ended 30Th September 2025. | View |
| 2025-10-31 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-10-30 | Board Meeting Intimation for Considering Take On Record And Approving The Un-Audited Financial Results Of The Company For The Quarter And Half Year Ended On 30Th September 2025 | View |
| 2025-10-16 | INTIMATION OF MERGER OF TWO MATERIAL WHOLLY-OWNED STEP-DOWN SUBSIDIARIES OF THE COMPANY | View |
| 2025-10-09 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-10-07 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2025-09-30 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-09-29 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2025-09-29 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-09-29 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |